Zolmitriptan Spray, Metered
Product Images NDC 69238-2352

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Zolmitriptan (NDC 69238-2352). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Chemical Structure (Zolmitriptan Nasal Spray Grunenthal 1)

Chemical Structure (Zolmitriptan Nasal Spray Grunenthal 1)
FDA Label Image

5 mg Carton (Zolmitriptan Nasal Spray Grunenthal 10)

5 mg Carton (Zolmitriptan Nasal Spray Grunenthal 10)
This text contains information regarding "Zolmitriptan Nasal Spray" with a concentration of 5mg for intranasal use. The product is distributed by Amneal Pharmaceuticals LLC and this pack includes 6 single-use nasal spray devices. It also mentions the manufacturer as Zolmitriptan and provides an address in Italy. The prescription is indicated as Rx only.*
FDA Label Image

Figure 1 (Zolmitriptan Nasal Spray Grunenthal 2)

Figure 1 (Zolmitriptan Nasal Spray Grunenthal 2)
Estimated probability of response is provided in the chart for different time points after the initial dose of medication. The data appears to show the response rate over time, likely for a clinical trial or study.*
FDA Label Image

Figure 2 (Zolmitriptan Nasal Spray Grunenthal 3)

Figure 2 (Zolmitriptan Nasal Spray Grunenthal 3)
Estimated probability of taking an escape medication (%) is provided in a table or chart showcasing the relationship with time elapsed in hours from the initial dose. The text includes a mathematical expression involving "e" but is partially garbled due to errors.*
FDA Label Image

Figure 3 (Zolmitriptan Nasal Spray Grunenthal 4)

Figure 3 (Zolmitriptan Nasal Spray Grunenthal 4)
This appears to be a comparison study evaluating Zolmitriptan 5 mg versus Placebo in a group of 231 participants for Zolmitriptan and 253 for Placebo. The study may include data on the estimated probability of rescue medication use over time post dose in hours.*
FDA Label Image

Figure A (Zolmitriptan Nasal Spray Grunenthal 5)

Figure A (Zolmitriptan Nasal Spray Grunenthal 5)
FDA Label Image

Figure B (Zolmitriptan Nasal Spray Grunenthal 6)

Figure B (Zolmitriptan Nasal Spray Grunenthal 6)
FDA Label Image

Figure C (Zolmitriptan Nasal Spray Grunenthal 7)

Figure C (Zolmitriptan Nasal Spray Grunenthal 7)
FDA Label Image

Figure D (Zolmitriptan Nasal Spray Grunenthal 8)

Figure D (Zolmitriptan Nasal Spray Grunenthal 8)
FDA Label Image

2.5 mg Carton (Zolmitriptan Nasal Spray Grunenthal 9)

2.5 mg Carton (Zolmitriptan Nasal Spray Grunenthal 9)
This text is a description of a Zolmitriptan Nasal Spray with a concentration of 2.5mg per spray device. It is indicated for intranasal use only. The packaging contains 6 single-use nasal spray devices. The product is manufactured by Farmaceutici Formenti S.p.A. and distributed by Amneal Pharmaceuticals. The contact number provided for inquiries is 1-877-835-9472.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.